Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of neonatal thrombocytopenia in a context of maternal antiplatelet alloimmunization: Expert opinion of the French-speaking working group.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2019
Same author

Distribution of Leaf-Feeding Beetles and Bean pod mottle virus (BPMV) in Illinois and Transmission of BPMV in Soybean.

Plant disease·2019
Same author

[Blood transfusion in neonatology: Study of practical aspects in 2016 in France, excluding acute bleeding or surgical care].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2018
Same author

TRANSCRIPTION. Recruitment of RNA polymerase II by the pioneer transcription factor PHA-4.

Science (New York, N.Y.)·2015
Same author

Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study.

European journal of cancer care·2013
Same author

Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States.

Annals of surgical oncology·2013

Related Experiment Video

Updated: May 20, 2026

Teasing Out the Interplay Between Natural Killer Cells and Nociceptor Neurons
09:40

Teasing Out the Interplay Between Natural Killer Cells and Nociceptor Neurons

Published on: June 30, 2022

Transient decrease in nociceptor GRK2 expression produces long-term enhancement in inflammatory pain.

L F Ferrari1, O Bogen, N Alessandri-Haber

  • 1Departments of Medicine and Oral Surgery, and Division of Neuroscience, University of California at San Francisco, 521 Parnassus Avenue, San Francisco, CA 94143-0440, USA.

Neuroscience
|July 17, 2012
PubMed
Summary
This summary is machine-generated.

Decreasing G-protein-coupled receptor kinase 2 (GRK2) in pain-sensing neurons causes longer-lasting pain hypersensitivity. This suggests GRK2 plays a key role in developing chronic pain after inflammation.

Related Experiment Videos

Last Updated: May 20, 2026

Teasing Out the Interplay Between Natural Killer Cells and Nociceptor Neurons
09:40

Teasing Out the Interplay Between Natural Killer Cells and Nociceptor Neurons

Published on: June 30, 2022

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pain Research

Background:

  • Attenuation of G-protein-coupled receptor kinase 2 (GRK2) in nociceptors is linked to heightened inflammatory hyperalgesia.
  • Understanding GRK2's role in nociceptor function is crucial for pain management.

Purpose of the Study:

  • To investigate the functional consequences of reversibly decreasing GRK2 expression in nociceptors.
  • To elucidate the molecular mechanisms underlying GRK2-mediated changes in pain sensitivity.

Main Methods:

  • Utilized intrathecal antisense oligodeoxynucleotide (AS-ODN) to temporarily reduce GRK2 expression in mice and rats.
  • Administered hyperalgesic agents like prostaglandin E(2), epinephrine, and carrageenan.
  • Assessed pain hypersensitivity and its duration post-treatment.
  • Investigated the involvement of protein kinase A (PKA) and Src tyrosine kinase (Src).

Main Results:

  • GRK2 AS-ODN administration resulted in enhanced and prolonged hyperalgesia.
  • This effect persisted for two weeks, even after GRK2 protein levels recovered, indicating neuroplastic changes.
  • The observed hyperalgesia was independent of protein kinase C epsilon (PKCε) and cytoplasmic polyadenylation element binding protein (CPEB).
  • The phenomenon was dependent on protein kinase A (PKA) and Src tyrosine kinase (Src).
  • GRK2 AS-ODN treated rats showed enhanced hyperalgesia upon direct activation of downstream signaling molecules.

Conclusions:

  • Transient GRK2 attenuation induces long-lasting neuroplastic changes in nociceptor function, leading to prolonged hyperalgesia.
  • The mechanism involves PKA and Src signaling pathways, downstream of G-protein-coupled receptors.
  • Reduced GRK2 during inflammation may contribute to the development of chronic pain after acute inflammatory conditions resolve.